Passer au contenu principal
Mandats représentatifs

Catalyst Capital Group US$290 million sale of its portfolio company, Therapure Biopharma

Fasken
Temps de lecture 1 minutes S'inscrire

Aperçu

Mandat

Therapure Biopharma

Advised Therapure Biopharma Inc., a Canada-based contract manufacturing and drug development company engaged in developing, manufacturing, purifying and packaging of therapeutic proteins and biosimilars for biopharmaceutical companies, in its sale of its contract development and manufacturing business to 3SBio Inc. and CITIC Private Equity Funds Management Co Ltd. 3SBio Inc. is a listed China-based company engaged in the research, development, manufacture and marketing of biopharmaceutical products, headquartered in Shenyang. CITIC Private Equity Funds Management Co Ltd is a China-based private equity and venture capital firm, headquartered in Beijing.

Équipe

    Abonnement

    Recevez des mises à jour de notre équipe

    S'inscrire